Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system

Overview of attention for article published in Frontiers in Pharmacology, December 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,883 followers.

New Research: Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system https://t.co/AGgDgEjvTj #pharmacology

01 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.